(Total Views: 356)
Posted On: 12/23/2019 9:38:27 AM
Post# of 149264
Re: ClosetInvestor #13517
First patient had 0 CTCs at 8 weeks. Testing data from second patient is just at 3 weeks.
Quote:
Further data from the first mTNBC cancer patient continues to show no detectable circulating tumor cells (CTC) or putative metastatic tumor cells in the peripheral blood and additional reductions in CCR5 expression on cancer-associated cells at 11 weeks of treatment with leronlimab. Additional data in an emergency IND protocol involving one MBC patient demonstrated shrinkage of tumor (via MRI) after three weeks of treatment with leronlimab.
(0)
(0)Scroll down for more posts ▼
